Odyssean »

Enact Hldgs shares owned by Odyssean

Quarter-by-quarter ownership of Enact Hldgs (ACT) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Enact Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Enact Hldgs held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enact Hldgs by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 28k 45.71

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Enact Hldgs

BlackRock
Dimensional Fund Advisors
Vanguard Portfolio Management
First Trust Advisors
Glendon Capital Management
Vanguard Capital Management
State Street Corporation
LSV Asset Management
American Century Companies
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Allianz Asset Management
Morgan Stanley
Invesco
Two Sigma Investments

View all funds holding Enact Hldgs